Co-Authors
This is a "connection" page, showing publications co-authored by Takaji Wakita and Shuetsu Fukushi.
Connection Strength
0.119
-
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants. Immunity. 2021 08 10; 54(8):1841-1852.e4.
Score: 0.060
-
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Front Microbiol. 2021; 12:651403.
Score: 0.059